Inactive Instrument

Highlights 2cureX AB (publ) Nasdaq Stockholm

Equities

SE0010468124

Highlights

Unlock all the news: Be the first to know and act before the market!

2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02	CI
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12	CI
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11	CI
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	26/23/26	CI
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	11/23/11	MT
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation	30/23/30	CI
2cureX AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/23/24	CI
2cureX AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
2cureX AB Provides Sales Guidance for Second Quarter	12/23/12	CI
2cureX Announces Launch of Updated Specimen Collection Set	23/23/23	CI
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23/23/23	CI
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2022	23/23/23	CI
2CureX and Pedoc Medical Sign Distribution Agreement	20/22/20	CI
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
2cureX AB Announces Distribution Agreement with Werfen	19/22/19	CI
2cureX AB Signs IndiTreat Distribution Agreement for Romania with Onco Systems S.r.l	01/22/01	CI
2cureX AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25	CI
2Curex AB and Gamidor Diagnostics Ltd. Enters into Distribution Agreement of IndiTreat® to Israel	28/22/28	CI
2Curex Has Signs A Distribution Agreement with Algol Diagnostics Oy	31/22/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights 2cureX AB (publ) Nasdaq Stockholm

Equities

SE0010468124

Highlights

Filters